The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
about
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2Origins of HIV and the AIDS pandemicThe restriction factors of human immunodeficiency virusHIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsBST-2/tetherin: a new component of the innate immune response to enveloped virusesAntiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteractionVpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanismThe role of BST-2/Tetherin in host protection and disease manifestationConformational changes induced by a single amino acid substitution in thetrans-membrane domain of Vpu: Implications for HIV-1 susceptibility to channel blocking drugsEvidence that the human foamy virus genome is DNACounteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu geneVpu and BST2: Still Not There Yet?Lack of adaptation to human tetherin in HIV-1 group O and P.HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variantsNovel approaches to inhibiting HIV-1 replication.Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Foamy viruses are unconventional retrovirusesFunctional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.The roles of Pol and Env in the assembly pathway of human foamy virus.Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.Human immunodeficiency virus and AIDS: insights from animal lentivirusesViral protein U counteracts a human host cell restriction that inhibits HIV-1 particle productionThe interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIVNef proteins from simian immunodeficiency viruses are tetherin antagonists.Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent mannerA variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cellsTetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.Viroporins customize host cells for efficient viral propagation.Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.Human cellular restriction factors that target HIV-1 replication.HIV-1 Vpu - an ion channel in search of a job.Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.
P2860
Q21559418-91B34466-026E-4D3B-A196-8801D805DDAAQ22242661-8FF1BC64-3E8F-42AE-92F7-5ACDBC389C6DQ24605108-3E1C575D-1011-47D4-8137-BF3567C67777Q24619066-5D2F08B2-DD23-4BE2-93B2-DC6B8956FD28Q24630382-63F3BCB5-E799-4B34-A9A6-5794CC3AB642Q24635271-917BBB73-6E6E-4F80-9C1C-6328E92EB8EDQ24644811-BFE16CD4-A768-42C8-8245-749E62E6BF4EQ26752737-FCD9FB82-F40A-4C5E-93B4-02818484765CQ27647751-E7DBB2F9-3907-46C0-8B01-EF0EA2D0F3BAQ28293371-02D9E929-519C-4B03-AE9F-81FE2351B6A0Q28730542-6EB379B3-328D-4BD2-8061-4239BA2808B5Q28730708-2438C328-51A5-4246-8FE5-70EC0F62E909Q30407564-5F01049D-F52B-4772-B75F-658EB34B0C07Q30815492-3F4EA898-AED6-4409-8B55-740BB0912EEBQ30968332-720C805E-D8F1-4F63-BC62-8F364BAAF257Q33408799-8BABD2F3-699E-41E5-9A66-0A99A36C1EAFQ33624690-40A84CAE-CDC2-4357-9C51-23F3E2DA3909Q33638829-FAEB1C1D-D08A-4620-AE54-FB1B670FADC8Q33639849-F266C8A8-D9AC-41A1-9407-535FF343D4B9Q33640055-B98A654C-ABB7-4B16-83C4-3616EEFD3367Q33652656-9A03C53C-2F6D-49FB-A576-CA4DC0588741Q33737672-99CD5CA7-D1E5-4CCF-AF75-363CAB325634Q33782618-21F01FA7-D624-4735-B990-2542AABE692BQ33807551-43265E3C-BB03-48FF-8846-92D4778CD64FQ33809273-D5AB1DE5-51D6-42FE-981F-F8EC5C2B28EDQ34391721-783CB710-6545-4DE3-A82D-2BD1C1B694B5Q34492477-C9F44D6A-2410-4032-99E5-54231181B708Q34505213-0322AB2B-7C73-4D2A-A24B-6F942310EEEBQ34658653-DA46C71A-1FE5-4262-BC7A-1EE6D51078ABQ35859611-73A53C47-DC7D-41CA-B386-95B9B5143884Q35873115-E8015ECC-01B2-42F4-828C-10AEB4D05E3DQ35922462-3D31D6A4-942F-4756-A01E-048E7ABA763BQ36339979-CACE9642-A094-45D7-9A25-D770D458CFF8Q36911742-C7FE4F13-4AF0-4BDD-8BC1-FC1CF995A243Q37115285-9C4F2869-39FE-41AB-A72E-71CC115A8FA7Q37202578-1A231580-7634-407E-914F-F51E57A2139AQ37378819-E6F871F7-EE40-44DF-B355-F2D8CA11F011Q37382519-836B0B5B-7F04-43C4-838C-132971D51160Q37384691-B460CF7A-A124-4997-BED0-7AF7E2A71846Q37448301-6E26C788-4D62-4382-B1A8-6E07879E660E
P2860
The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@ast
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@en
type
label
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@ast
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@en
prefLabel
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@ast
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@en
P2093
P2860
P1433
P1476
The envelope glycoprotein of h ...... le release: a Vpu-like factor?
@en
P2093
P2860
P304
P407
P50
P577
1996-02-01T00:00:00Z